Gamma Investing LLC Alkermes Plc. Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Gamma Investing LLC holds 4,963 shares of ALKS stock, worth $135,787. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,963
Previous 5,396
8.02%
Holding current value
$135,787
Previous $178 Million
20.31%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ALKS
# of Institutions
394Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$796 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$506 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$275 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$225 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$175 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.49B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...